RIZATRIPTAN TW rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Kupite ga zdaj

Javno poročilo o oceni Javno poročilo o oceni (PAR)
26-11-2017

Aktivna sestavina:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Dostopno od:

Arrotex Pharmaceuticals Pty Ltd

INN (mednarodno ime):

rizatriptan benzoate

Farmacevtska oblika:

Tablet, orally disintegrating

Sestava:

Excipient Ingredients: mannitol; crospovidone; sodium stearylfumarate; ethylcellulose; colloidal anhydrous silica; silicon dioxide; hypromellose; acesulfame potassium; Flavour

Pot uporabe:

Sublingual

Enote v paketu:

3, 2, 6

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

for acute treatment of migraine attacks with or without aura.

Povzetek izdelek:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status dovoljenje:

Licence status A

Datum dovoljenje:

2015-03-20